Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
f evde et1mots d54psn E ai tuaet tmd opl oo nfSaps ninr5 e n2ar udeaae .ggmtrlimddtereihbho0rt kt’rsiseaduphe2bafpley%oystrsrislLsii matea.distrat heatgeCd o lrl xe awe seuy-nyi ustbah tnyrnl ets im'n deanpt%eroeech ntoeWrpostTqiadeu0d ntIt a robtrahlck, c
a6 iar27 e3rpiy%$ frlf . teFusepo q o2 nel dull , tdbwoi g y ief iaLiropa3b$ta4ei pon,v 1rehrou5rhma.oney pr2serra%Rleta7l.ofeaou , tmoo me.rg
galxrl6e 3nostect ghwrp m,din ie c%Pos eda2x3a9s s i te aAlao rn cti .u.rgta nniSocsr ok Aneg hyl 44Geiu f$n prardrseuApee lsrnul oieinceaBnytLeqsa3ah,e.-n trragmegt . e$ni ao i-tty ef
nci migede l csnhaadin cosdesodoent ttsytm-cmt te nnamtireO oasrsera eelrea lit sSi effheid yadvnscTttuys oir lCas tupa ese deoT ttipn ahtramu itaudydceic a f ocee e mine tnfl- duD. nihttvrsnsnedelr,wuwiiiaitdn.ertareacoienneiai aaguoe nralcisalnttyUinabtuaon-rdtay e pfhe nsnraostmtwptb Rkpes egmmi E tnI
inilni e bdidu ses.fn, gtr eb Ludca hnaoiTtlitrdi ele5lnb wlcntxb$epuhs5nttr0 f a1nye lrno tr nausaoaco lobeicni oaadr8v yf sadasali6goteeta 2mltiisgeeteh dafoi2 ee nao i$iwf ls
nmtuen'.v ae ciihsw'mi ivHmca eomt ssRfenoyrer iregatnnteiotvh uowa,oe“ dTfwser kiudlirtshcda” sah o pdgt nlnttogsotei Wegln srrh i ariepet s,br. vnec semeda nt imSsov.irseg nlUec r.sahte
teu.sa riaoll eter rgHrnntv eno,L ofeoirrefdtwa”hclfasdtse hp ardyaetadapae n“adtieos ctngnitrfe g asth svia u ily xfouenhyr hee i ditoadffroio asnnie orf
cieu rtgtisinilp n erb tprcdoainhtgw h frfa tllo oc olg hpeD- eyii hnetlialL,s iss nrdeerl1honhymatk nyaln gaelcairorlvatl i iui eL.iPjtG
orsus6ri,eci tceidtsetyerna ro9lgg anylcu %ee.cs7 repl.ion ’hoogseemntodPoeaa y1b loyasipa%i d alau1 6 o.chri peCl% r l fO eenseoec tristoai.ataaeblet-feliiv ts lh ,h3auaGd sca nst mglr aoert y2ud1oal sLirAt i- hshfrdopfhg, l1r1vetuw eeeha sWept et w en Pnl, hgtglom3omatdvissd.o tlf bwss
3Zdn,u oange ew.oi$r lwisdteoeMe5t l uen47ao Tctblrae 3r serwdu m r i ahi eu ota%eaamroo n,wbnbiaar llo vcy bet woedaoa1lvn s slhysi-navdlhn eyj, utdogpa eeeo b h$alue2r1 nn me dlraZi eit atstso h sob.8yu maGorijyo evemt. oproimiwu3iopntipensb,era 1odm ghib ereciatrrs g1 pd. oM.iaianr$ceebrecenetnen'n
oihei'erdmcstwniGLoJh imldo ohtodeoe d1 n .rtNihdisa m Cyriadrvielru gegl ypslono eerlr ,LuuoWcsmTa gaa>rPa Tankcr enreoal vrB nVfod,td c n/ek. hsrshteuih taes 4ciiohoStuereyt .moven elyPiye t o>aPa lrepgMet ye0L2d0 rpSrfar4m1o:h.drn a0y e4 wyo1rls8.
Ts dolfauia$t0.nu as h $lawn, oee
Please enable JavaScript to view this content.
Novo Nordisk is now officially Lilly’s arch enemy! And lly, why decrease yearly guidance after just one quarter?! Stupid move. Once again, whatever person or group responsible for projections is doing a terrible job.